These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10070310)

  • 1. K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa.
    Zhang H; Nordenskjöld B; Dufmats M; Söderkvist P; Sun XF
    Eur J Cancer; 1998 Dec; 34(13):2053-7. PubMed ID: 10070310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
    Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
    Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM
    Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma.
    Laurent-Puig P; Olschwang S; Delattre O; Validire P; Melot T; Mosseri V; Salmon RJ; Thomas G
    Int J Cancer; 1991 Sep; 49(2):220-3. PubMed ID: 1652568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of K-ras mutations throughout the natural history of human colorectal cancer.
    Losi L; Benhattar J; Costa J
    Eur J Cancer; 1992; 28A(6-7):1115-20. PubMed ID: 1627381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
    Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
    Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors.
    Ichikawa Y; Nishida M; Suzuki H; Yoshida S; Tsunoda H; Kubo T; Uchida K; Miwa M
    Cancer Res; 1994 Jan; 54(1):33-5. PubMed ID: 8261457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A relationship between K-ras gene mutations and some clinical and histologic variables in patients with primary colorectal carcinoma.
    Beránek M; Bures J; Palicka V; Jandík P; Langr F; Nejedlá E
    Clin Chem Lab Med; 1999 Jul; 37(7):723-7. PubMed ID: 10510729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
    Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
    Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of K-RAS mutation detection in colorectal cancer and in surgical margins of the colon.
    Okulczyk B; Kovalchuk O; Piotrowski Z; Myśliwiec P; Chyczewski L
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():52-4. PubMed ID: 15638373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
    Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
    J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
    Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
    Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras oncogene activation in benign and malignant colorectal tumours.
    Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
    Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinico-pathological associations of ras mutations in colorectal cancer in the Victorian population.
    Thomas RJ; Liu YS; St Clair F; Norris PM; Valentine R; Phillips WA
    Aust N Z J Surg; 1997 May; 67(5):233-8. PubMed ID: 9152150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces.
    Ratto C; Flamini G; Sofo L; Nucera P; Ippoliti M; Curigliano G; Ferretti G; Sgambato A; Merico M; Doglietto GB; Cittadini A; Crucitti F
    Dis Colon Rectum; 1996 Nov; 39(11):1238-44. PubMed ID: 8918432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
    Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
    Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.